Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trial.
Saved in:
| Title: | Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trial. |
|---|---|
| Authors: | Dauccia C; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Academic Trials Promoting Team, Institut Jules Bordet, Bruxelles, Belgium; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., Franzoi MA; Cancer Survivorship Group, INSERM 981 - Department for the Organization of Patient Pathways, Gustave Roussy, France., Saura C; Vall d'Hebrón University Hospital, Vall d'Hebrón Institute of Oncology, Barcelona, Spain., Hlauschek D; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria., Sölkner L; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria., Gnant M; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria; Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria., Dubsky PC; Tumour, and Breast Cancer Centre, Hirslanden Klinik St. Anna, Lucerne, Switzerland., Helfgott R; Department of Surgery, Ordensklinikum Linz - Sisters of Charity, Linz, Austria., Zoppoli G; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy; Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Oliveira M; Vall d'Hebrón University Hospital, Vall d'Hebrón Institute of Oncology, Barcelona, Spain., Collet L; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Academic Trials Promoting Team, Institut Jules Bordet, Bruxelles, Belgium., Fredrickson J; Genentech, Inc., South San Francisco, California, USA., Wilson TR; Genentech, Inc., South San Francisco, California, USA., Arecco L; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Academic Trials Promoting Team, Institut Jules Bordet, Bruxelles, Belgium., Agostinetto E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Academic Trials Promoting Team, Institut Jules Bordet, Bruxelles, Belgium. Electronic address: elisa.agostinetto@hubruxelles.be., de Azambuja E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Academic Trials Promoting Team, Institut Jules Bordet, Bruxelles, Belgium. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 12; Vol. 244, pp. 116880. Date of Electronic Publication: 2026 Jun 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
